Transcription factor NF-κB: Friend or foe of neurons?

Molecular Psychiatry

Volumn 3, Issue 1, 1998, Pages 15-20

  Lezoualc'h, F ^a   Behl, C ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Alzheimer's disease; Neurodegeneration; Neuroprotection; NF B; Oxidative stress; Transcription factors

Indexed keywords

ANTIOXIDANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROTOXIN; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; CELL DEATH; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MACROMOLECULE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0031962438     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000295     Document Type: Review

References (78)

1. Hall ED, Braughler JM. Central nervous sytem trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic Biol Med 1989; 6: 289-301.
2. Hall ED, Braughler JM. Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic Biol Med 1989; 6: 303-313.
3. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1932; 59: 1609-1623.
4. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330: 613-622.
5. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90: 7915-7922.
6. Olanow CW. A radical hypothesis for neurodegeneration. Trends Neurosci 1993; 16: 439-444.
7. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. Oxford University Press: Oxford, 1989, pp 188-266.
8. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants and human diseases: where are we now? J Lab Clin Med 1992; 119: 598-620.
9. Behl C, Davis J, Cole GM, Schubert D. Vitamin E protects nerve cells from amyloid β-protein toxicity. Biochem Biophys Res Commun 1992; 186: 944-952.
10. Reiter RJ. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation. Front Neuroendocrinol 1995; 16: 383-415.
11. Zhao W, Richardson JS, Mombourquette MJ, Weil JA. An in vitro EPR study of the free radical scavenging actions of the lazaroids antioxidants U-74500A and U-7851F. Free Radic Biol Med 1995; 19: 21-30.
12. Lezoualc'h F, Skutella T, Widmann M, Behl C. Melatonin prevents oxidative stress-induced cell death in hippocampal cells. Neuroreport 1996; 7: 2071-2077.
13. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 1993; 12: 2005-2015.
14. Pahl HL, Baeuerle PA. Oxygen and the control of gene expression. Bioessays 1994; 16: 497-502.
15. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991; 10: 2247-2258.
16. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986; 46: 705-716.
17. Grilli M, Chiu JJ, Lenardo MJ. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993; 143: 1-62.
18. Baeuerle P, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141-179.
19. Baldwin AS. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-683.
20. Baeuerle PA. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochem Biophys Acta 1991; 1072: 63-80.
21. Miamoto S, Verma IM. Rel/NF-κB/IκB story. Adv Cancer Res 1995; 66: 255-292.
22. Baeuerle P, Baltimore D, NF-κB: ten years after. Cell 1996; 87: 13-20.
23. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev 1995; 9: 2723-2735.
24. Baeuerle P, Baltimore D. IκB: a specific inhibitor of the NF-κB transcription factor. Science 1988; 242: 540-546.
25. Inoue J, Kerr LD, Kakizuka A, Verma IM. IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: a new member of the IκB family. Cell 1992; 68: 1109-1120.
26. Hatada EN, Naumann M, Scheidereit C. Common structural constituents confer IκB activity to NF-κB p105 and IκB/MAD-3. EMBO J 1993; 12: 2781-2788.
27. Beg AA, Baldwin AS Jr. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev 1993; 7: 2064-2070.
28. Zabel U, Henkel T, Silva MS, Baeuerle PA. Nuclear uptake control of NF-κB by MAD-3, an I kappa B protein present in the nucleus. EMBO J 1993; 12: 201-211.
29. Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allg Zeitschr Psychiatr Psychisch-Gerichtl Mediz 1907; 64: 146-148.
30. Glenner GG. Alzheimer's disease: its proteins and genes. Cell 1988; 52: 307-308.
31. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994; 77: 817-827.
32. Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 1990; 250: 279-282.
33. Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve RL. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989; 245: 417-429.
34. Koh JY, Yan LL, Cotman CW. β amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 1990; 533: 315-320.
35. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel R. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992; 12: 376-389.
36. Iversen LL, Mortishire-Smith RJ, Pollack SJ, Shearman MS. The toxicity in vitro of β-amyloid protein. Biochem J 1995; 311: 1-16.
37. Yankner BA. Commentary and perspective on studies of beta amyloid neurotoxicity. Neurobiol Aging 1992; 13: 615-616.
38. Yankner BA. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 1996; 16: 921-922.
39. Yan SD, Yan SH, Chen X, Fu J, Chen M, Kuppusamy P, Smith M, Perry G, Godman G, Nawroth P, Zweier J, Stern D. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nature Med 1995; 7: 693-699.
40. Terai K, Matsuo A, McGeer PL. Enhancement of immunoreactivity for NF-κB in the hippocampal formation and cerebral cortex of Alzheimer's disease. Brain Res 1996; 735: 159-168.
41. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-259.
42. Terry RD, Katzman R, Bick KL (eds). Alzheimer's Disease. Raven Press: New York, 1994.
43. May PC, Boggs LN, Fuson KS. Neurotoxicity of human amylin in rat primary hippocampal cultures: similarities to Alzheimer's disease amyloid-beta neurotoxicity. J Neurochem 1993; 61: 2330-2333.
44. Lorenzo A, Razzaboni B, Weir C, Yankner BA. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 1994; 368: 756-750.
45. Schubert D, Behl C, Lesley R, Brack A, Dargusch R, Sagara Y, Kimura H. Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci USA 1995; 92: 1989-1993.
46. Lezoualc'h F, Behl C. Activation of NF-κB transcription factor is a common molecular signal in cell death induced by β-amyloid, amylin and hydrogen peroxide. Alzheimer's Research 1997; 3: 43-50.
47. Kaltschmidt T, C, Kaltschmidt B, Baeuerle P. Stimulation of ionotropic glutamate receptors activates transcription factor NF-κB in primary cultures. Proc Natl Acad Sci USA 1995; 92: 9618-9622.
48. Choi DW. Glutamate toxicity and diseases of the nervous sytem. Neuron 1988; 1: 623-634.
49. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689-695.
50. Rong Y, Baudry M. Seizure activity results in a rapid induction of nuclear factor-κB in adult but not juvenile rat limbic structures. J Neurochem 1996; 67: 662-668.
51. Beg AA, Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 1996; 274: 782-784.
52. Wang CY, Mayo MW, Baldwin AS Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 1996; 274: 784-787.
53. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-α-induced apoptosis by NF-κB. Science 1996; 274: 787-789.
54. Liu ZG, Hsu HL, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 1996; 87: 565-576.
55. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994; 78: 539-542.
56. Grilli M, Pizzi M, Memo M, Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 1996; 274: 1383-1385.
57. Behl C, Widmann M, Trapp T, Holsboer F. 17-β estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 1995; 216: 473-482.
58. 2+ accumulation. Proc Natl Acad Sci USA 1995; 92: 9328-9332.
59. Barger SW, Mattson MP. Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor. Mol Brain Res 1996; 40: 116-126.
60. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel R. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 1993; 10: 243-254.
61. Schubert D, Behl C. The expression of amyloid beta protein precursor protects nerve cells from β-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix. Brain Res 1993; 629: 275-282.
62. Grilli M, Ribola M, Alberici A, Valerio A, Memo M, Spano P. Identification and characterisation of a κB/Rel binding site in the regulatory region of the APP gene. J Biol Chem 1995; 270: 26774-26777.
63. Grilli M, Goffi F, Memo M, Spano P. Interleukin-1β and glutamate activate the NF-κB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal culture. J Biol Chem 1996; 271: 15002-15007.
64. Friedman WJ, Thakur S, Seidman L, Rabson AB. Regulation of Nerve Growth Factor mRNA by Interleukin-1 in rat hippocampal astrocytes is mediated by NF-κB. J Biol Chem 1996; 271: 31115-31120.
65. Sparacio SM, Zhang Y, Vilcek J, Benveniste EN. Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κB-like nuclear protein. J Neuroimmunol 1992; 39: 231-242.
66. Lipton SA. Janus faces of NF-κB: neurodestruction versus neuroprotection. Nature Med 1997; 3: 20-22.
67. Lin KI, Lee SH, Narayanan R, Baraban JM, Hardwick JM, Ratan RR. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-κB. J Cell Biol 1995; 131: 1149-1161.
68. Schöbitz B, de Kloet ER, Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog Neurobiol 1994; 44: 397-432.
69. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol 1994; 10: 405-455.
70. Greene LA, Tischler AS. Establishment of a noradrenergic clonal cell line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976; 73: 2424-2428.
71. Sagara Y, Dargusch R, Klier FG, Schubert D, Behl C. Increased antioxidant enzyme activity in amyloid β protein-resistant cells. J Neurosci 1996; 16: 497-505.
72. Behl C, Lezoualc'h F, Widmann M, Rupprecht R, Holsboer F. Oxidative stress-resistant cells are protected against haloperidol toxicity. Brain Res 1996; 717: 193-195.
73. Behl C, Rupprecht R, Skutella T, Holsboer F. Haloperidol-induced cell death - mechanism and protection with vitamin E in vitro. Neuroreport 1995; 7: 360-364.
74. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of IκB in mediation of immunnsuppression by glucocorticoids. Science 1995; 270: 283-286.
75. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 1995; 270: 286-290.
76. Behl C, Lezoualc'h F, Trapp T, Widmann M, Skutella T, Holsboer F. Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 1997; 138: 101-106.
77. Taglialatela G, Robinson R, Perez-Polo JR. Inhibition of nuclear factor kappa B (NF-κB) activity induces nerve growth factor-resistant apoptosis in PC12 cells. J Neurosci Res 1997; 47: 155-162.
78. Pike CJ, Cotman CW. Calretinin-immunoreactive neurons are resistant to β-amyloid toxicity in vivo. Brain Res 1995; 671: 293-298.